1. Eris Lifesciences
stock logo

88% Buy

Eris Lifesciences Share Price

ERIS

₹1,315.00-₹32.15 (-2.39%) TodayLast updated on 04 Nov, 2024 | 15:29 IST

Eris Lifesciences Share Price Chart

Please wait...
  • About Eris Lifesciences
  • Fundamentals
  • Events
  • More
  • News

About Eris Lifesciences

Eris Lifesciences Financials

arrow
Market cap
Market Cap Switch₹17,933 Crs
Open
₹1,345.00
Close
₹1,347.15
Circuit range
₹1,581.05 - ₹1,054.05
Day range
₹1,302.00 - ₹1,347.15
Year range
₹809.15 - ₹1,522.05
Volume
67,879
Avg. traded
₹1,315.88
Revenue (12m)
₹2,498 Crs
Eris LifesciencesEris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.

Eris Lifesciences Key indicators

arrow
52 week high
₹1,522.05
52 week low
₹809.15
P/E ratio
51.52
P/B ratio
6.42
ROE
12.65%
ROCE
10.17%
Dividend yield
--
Debt/Equity ratio
1
EPS
22.03

Learn more

Investment checklist: (4/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

88%

Hold

12%

Sell

0%

This analysis is based on the reviews of 8 experts in the last 7 days

Eris Lifesciences Fundamentals

Eris Lifesciences Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

31.28%

Net profit margin

19.19%

ROE

12.65%

ROA

7.79%

ROCE

10.17%

Learn more

Eris Lifesciences Shareholder returns

arrow
1 day
-2.20%
1 week
+2.85%
1 month
-2.45%
3 months
+17.53%
1 year
+50.92%
3 years
+61.60%
5 years
+213.22%

Eris Lifesciences Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹1,345.00
₹1,317.55
-2.20%
Fri, Nov 1 2024
₹1,327.00
₹1,347.15
+1.81%
Thu, Oct 31 2024
₹1,280.00
₹1,323.15
+2.56%
Wed, Oct 30 2024
₹1,302.55
₹1,290.10
-0.96%
Tue, Oct 29 2024
₹1,289.00
₹1,302.55
+1.68%
Mon, Oct 28 2024
₹1,274.35
₹1,281.00
-0.85%
Fri, Oct 25 2024
₹1,282.50
₹1,292.00
+0.64%
Thu, Oct 24 2024
₹1,272.00
₹1,283.80
+0.54%

Eris Lifesciences Shareholding Pattern

arrow

Promoters (54.87%)

Mutual Funds (17.03%)

Retail and other (18.47%)

Foreign institutions-FII (8%)

Other domestic institutions (1.61%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹7.35/share

    Ex date 11 Aug 2022

    expand tab

Learn more

FAQs on Eris Lifesciences